RATIONALE: There has been controversy over the abuse potential of methylphenidate (MPH) in the context of treatment for attention deficit hyperactivity disorder (ADHD). OBJECTIVE: The objective of this study was to compare the reinforcing and subjective effects of oral MPH in adults with and without ADHD. MATERIALS AND METHODS: Following screening, 33 adults (n = 16 with ADHD; n = 17 free from psychiatric diagnoses) completed four pairs of experimental sessions, each of which included a sampling session and a self-administration session. During sampling sessions, subjects received in randomized order 0 (placebo), 20, 40, and 60 mg MPH. During self-administration sessions, subjects completed a progressive ratio (PR) task to earn portions of the dose received on the corresponding sampling session. Subjective effects were recorded throughout all sessions. The main outcome measure for the study was the number of ratios completed on the PR task. Secondary measures included peak subjective effects and area-under-the-curve values for subjective effects. RESULTS: Compared to the control group, the ADHD group completed more ratios on the PR task. Both groups showed robust effects of methylphenidate on subjective endpoints. Main effects of group were noted on subjective effects involving concentration and arousal. CONCLUSIONS: Compared to placebo, MPH produced reinforcing effects only for the ADHD group and not for the control group. Increases in stimulant-related subjective effects in non-ADHD subjects were not associated with drug reinforcement.
RCT Entities:
RATIONALE: There has been controversy over the abuse potential of methylphenidate (MPH) in the context of treatment for attention deficit hyperactivity disorder (ADHD). OBJECTIVE: The objective of this study was to compare the reinforcing and subjective effects of oral MPH in adults with and without ADHD. MATERIALS AND METHODS: Following screening, 33 adults (n = 16 with ADHD; n = 17 free from psychiatric diagnoses) completed four pairs of experimental sessions, each of which included a sampling session and a self-administration session. During sampling sessions, subjects received in randomized order 0 (placebo), 20, 40, and 60 mg MPH. During self-administration sessions, subjects completed a progressive ratio (PR) task to earn portions of the dose received on the corresponding sampling session. Subjective effects were recorded throughout all sessions. The main outcome measure for the study was the number of ratios completed on the PR task. Secondary measures included peak subjective effects and area-under-the-curve values for subjective effects. RESULTS: Compared to the control group, the ADHD group completed more ratios on the PR task. Both groups showed robust effects of methylphenidate on subjective endpoints. Main effects of group were noted on subjective effects involving concentration and arousal. CONCLUSIONS: Compared to placebo, MPH produced reinforcing effects only for the ADHD group and not for the control group. Increases in stimulant-related subjective effects in non-ADHD subjects were not associated with drug reinforcement.
Authors: Klaus Henning Krause; Stefan H Dresel; Johanna Krause; Christian la Fougere; Manfred Ackenheil Journal: Neurosci Biobehav Rev Date: 2003-11 Impact factor: 8.989
Authors: Julie A Marusich; William Travis McCuddy; Joshua S Beckmann; Cassandra D Gipson; Michael T Bardo Journal: Behav Pharmacol Date: 2011-12 Impact factor: 2.293
Authors: Beth Levant; Troy J Zarcone; Paul F Davis; Marlies K Ozias; Stephen C Fowler Journal: J Pharmacol Exp Ther Date: 2010-12-28 Impact factor: 4.030
Authors: Scott H Kollins; Erin Schoenfelder; Joseph S English; F Joseph McClernon; Rachel E Dew; Scott D Lane Journal: Exp Clin Psychopharmacol Date: 2013-10 Impact factor: 3.157
Authors: Emily Carias; Dennis Fricke; Abisha Vijayashanthar; Lauren Smith; Rathini Somanesan; Connor Martin; Leanna Kalinowski; Daniel Popoola; Michael Hadjiargyrou; David E Komatsu; Panayotis K Thanos Journal: Behav Brain Res Date: 2018-08-24 Impact factor: 3.332
Authors: Scott H Kollins; Joseph S English; Michelle E Roley; Benjamin O'Brien; Justin Blair; Scott D Lane; F Joseph McClernon Journal: Psychopharmacology (Berl) Date: 2012-12-18 Impact factor: 4.530
Authors: Scott H Kollins; Erin N Schoenfelder; Joseph S English; Alex Holdaway; Elizabeth Van Voorhees; Benjamin R O'Brien; Rachel Dew; Allan K Chrisman Journal: J Subst Abuse Treat Date: 2014-08-07
Authors: J G Ramaekers; E A Evers; E L Theunissen; K P C Kuypers; A Goulas; P Stiers Journal: Psychopharmacology (Berl) Date: 2013-04-19 Impact factor: 4.530